Back to Authors

Sahebkar-Moghaddam, Farhad

A5026711360 | I1320553840

Mayo Clinic

Amgen (United States)

Citations 1

Erenumab Immunogenicity: a Pooled Analysis of Phase 2 and Phase 3 Migraine Prevention Clinical Trials (P4.098)

Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.90.15_supplement.p4.098